Literature DB >> 21893537

Twenty-first century vaccines.

Rino Rappuoli1.   

Abstract

In the twentieth century, vaccination has been possibly the greatest revolution in health. Together with hygiene and antibiotics, vaccination led to the elimination of many childhood infectious diseases and contributed to the increase in disability-free life expectancy that in Western societies rose from 50 to 78-85 years (Crimmins, E. M. & Finch, C. E. 2006 Proc. Natl Acad. Sci. USA 103, 498-503; Kirkwood, T. B. 2008 Nat. Med 10, 1177-1185). In the twenty-first century, vaccination will be expected to eliminate the remaining childhood infectious diseases, such as meningococcal meningitis, respiratory syncytial virus, group A streptococcus, and will address the health challenges of this century such as those associated with ageing, antibiotic resistance, emerging infectious diseases and poverty. However, for this to happen, we need to increase the public trust in vaccination so that vaccines can be perceived as the best insurance against most diseases across all ages.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893537      PMCID: PMC3146774          DOI: 10.1098/rstb.2011.0075

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  11 in total

1.  Global Advisory Committee on Vaccine Safety, 6-7 June 2006.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-07-14

2.  Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.

Authors:  William W Thompson; Cristofer Price; Barbara Goodson; David K Shay; Patti Benson; Virginia L Hinrichsen; Edwin Lewis; Eileen Eriksen; Paula Ray; S Michael Marcy; John Dunn; Lisa A Jackson; Tracy A Lieu; Steve Black; Gerrie Stewart; Eric S Weintraub; Robert L Davis; Frank DeStefano
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

3.  HIV/AIDS: money matters.

Authors:  Leslie Roberts; Barbara Jasny
Journal:  Science       Date:  2008-07-25       Impact factor: 47.728

4.  Rabies vaccine freed of the factor causing allergic encephalitis.

Authors:  J F BELL; J T WRIGHT; K HABEL
Journal:  Proc Soc Exp Biol Med       Date:  1949-03

5.  Infectious disease. New malaria plan called ambitious by some, unrealistic by others.

Authors:  Leslie Roberts
Journal:  Science       Date:  2008-10-03       Impact factor: 47.728

6.  Infectious disease. An ill wind, bringing meningitis.

Authors:  Leslie Roberts
Journal:  Science       Date:  2008-06-27       Impact factor: 47.728

7.  Infectious disease. Clinical trials: dispelling suspicions, building trust in Mali.

Authors:  Leslie Roberts
Journal:  Science       Date:  2008-06-27       Impact factor: 47.728

Review 8.  Therapeutic vaccines for chronic diseases: successes and technical challenges.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

9.  Cancer vaccines.

Authors:  Margaret A Liu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

10.  From Pasteur to genomics: progress and challenges in infectious diseases.

Authors:  Rino Rappuoli
Journal:  Nat Med       Date:  2004-11       Impact factor: 53.440

View more
  10 in total

1.  Vaccines and future global health needs.

Authors:  G J V Nossal
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

2.  The EPA: Time to Re-Invent Environmental Protection.

Authors:  Kenneth Olden
Journal:  Am J Public Health       Date:  2018-04       Impact factor: 9.308

3.  Vaccines and global health.

Authors:  Brian Greenwood; David Salisbury; Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

Review 4.  Clinical vaccine development.

Authors:  Seunghoon Han
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

5.  Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.

Authors:  Marcelo P Oliveira; Vívian T Martins; Thaís T O Santos; Daniela P Lage; Fernanda F Ramos; Beatriz C S Salles; Lourena E Costa; Daniel S Dias; Patrícia A F Ribeiro; Mônica S Schneider; Ricardo A Machado-de-Ávila; Antônio L Teixeira; Eduardo A F Coelho; Miguel A Chávez-Fumagalli
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

6.  An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.

Authors:  Hyun Ju In; Heeji Lim; Jung-Ah Lee; Hye Jin Kim; Jin-Won Kim; Ji-Yeon Hyeon; Sang-Gu Yeo; June-Woo Lee; Jung Sik Yoo; Young Ki Choi; Sang-Won Lee
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

Review 7.  Vaccines Against Antimicrobial Resistance.

Authors:  Roberto Rosini; Sonia Nicchi; Mariagrazia Pizza; Rino Rappuoli
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

Review 8.  Vaccine Evolution and Its Application to Fight Modern Threats.

Authors:  Emanuele Andreano; Ugo D'Oro; Rino Rappuoli; Oretta Finco
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

9.  A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A.

Authors:  Jacopo Enotarpi; Marta Tontini; Cristiana Balocchi; Daan van der Es; Ludovic Auberger; Evita Balducci; Filippo Carboni; Daniela Proietti; Daniele Casini; Dmitri V Filippov; Hermen S Overkleeft; Gijsbert A van der Marel; Cinzia Colombo; Maria Rosaria Romano; Francesco Berti; Paolo Costantino; Jeroen D C Codeé; Luigi Lay; Roberto Adamo
Journal:  Nat Commun       Date:  2020-09-07       Impact factor: 14.919

Review 10.  Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa.

Authors:  Giada Antonelli; Luigia Cappelli; Paolo Cinelli; Rossella Cuffaro; Benedetta Manca; Sonia Nicchi; Serena Tondi; Giacomo Vezzani; Viola Viviani; Isabel Delany; Maria Scarselli; Francesca Schiavetti
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.